Marc Hilhorst

Nephrologist-to-be specializing in autoimmune diseases

[Andrea Sánchez-Navarro @andrea_26sn]

No salt for me sir ✋🚫 next generation ready to fight against hypertension and #CKD #KidneyWk #KidneySTARS #ASN2022

[Marc Hilhorst @HilhorstMarc]

ERA EDTA Paris! #ERA22

[Maine-Anjou Research Group @MaineAnjouReg]

Y. Vegting and @HilhorstMarc updated this 2012 meta-analysis (ELISA only, whereas Tomasson included also IIF for ANCA detection). While still suffering from heterogeneity, this study reinforces the idea that ANCA rises do precede relapses #Vasculitis22 2/x

[KenWarringtonMD @MdWarrington]

Thrilled to see my #mentor recognized at #Vasculitis22

[Didier Hilhorst @didierh]

Life update: after 15 years in San Francisco 🇺🇸, we moved to Paris 🇫🇷! And… after 6 years, today is my last day @Uber — thank you for the ride 🚗. As for what’s next? Some time off first, and I’ll see next year what new adventures await! Here’s to a new chapter in life 🍾🥂.

[Nature Reviews Nephrology @NatRevNeph]

Innate immune response in the tubular system during trauma-related AKI.

https://t.co/XybIheULQf

[Frontiers - Immunology @FrontImmunol]

New Research: Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that was traditionally thought to… https://t.co/O2jJDbLKfF #immunology

[Hans-Joachim Anders @hjanders_hans]

IgAN: Glomerular CD206+ macrophages predict response to steroids in the diagnostic biopsy
https://t.co/ApTUzCzFHk @JASN_News
Check also our editorial on how to select the right IgAN pts for costly immunotherapies @HilhorstMarc https://t.co/jHUmud9I4W

[JASN_News @JASN_News]

March Highlights: Glomerular Exostosin Deposits in Membranous Lupus Nephritis—a Dialogue

This editorial from @HilhorstMarc and
@hjanders_hans discusses advancements in knowledge of lupus nephritis kidney biopsies and their relationship with EXT1/EXT2 https://t.co/fMXHh1gxVv

[JASN_News @JASN_News]

On kidney biopsy, the one-third of patients with membranous lupus nephritis who test positive for two proteins, exostosin 1 and 2, are less likely than EXT1/EXT2-negative patients to show biopsy findings signifying chronic disease or develop ESKD https://t.co/4y0hBwRXJN

[NDT @NDTsocial]

🆕Review:
The podocyte as a direct target of glucocorticoids in nephrotic syndrome
📸Schematic overview of proposed molecules affected by glucocorticoid treatment
📖https://t.co/jTm2UyINM8👈
@Nierstichting

[Sanjeev Sethi @SethiRenalPath]

1/6 Good editorial discussion by @hjanders_hans @HilhorstMarc on exostosin (EXT) in membranous lupus nephritis (LMN) based on our recent study: https://t.co/cw8dStrxP4

[Hans-Joachim Anders @hjanders_hans]

All you need to know about ANCA vasculitis. Epidemiology-Clinical Presentation- Pathophysiology, Diagnosis, Biomarkers, Management, QoL, Outlook, https://t.co/TpJzmfdc0B @eular_org @ERAEDTA @ISNkidneycare @GlomCon @RELENT_EU @DiseasePrimers